The BZLF1 open reading frame of Epstein–Barr virus (EBV) encodes an important transactivator of replication. During latency, transcription of this gene is switched off. HI motifs have been shown to cause negative regulation of the promoter. Using yeast one-hybrid assays, we isolated the E box-binding protein, E2-2, interacting with these motifs. Electrophoretic mobility shift assays demonstrated that E2-2 binds to HIα, HIβ and HIγ, which contain E box consensus binding sites. Deletion of the HI-associated E boxes and overexpression of E2-2 in transfection assays revealed that these elements act as repressors in lymphoid cells. In contrast, in epithelial cells they contribute to the increased responsiveness of the promoter to transactivation by the BZLF1 protein. The data presented are in accord with an alternative and exclusive binding of different cell type- and differentiation-specific factors, such as E2-2, to the HI-associated E boxes in lymphoid and epithelial cells. This implies a role in cell type-specific virus replication.
BeckerJ.,
LeserU.,
MarschallM.,
LangfordA.,
JilgW.,
GelderblomH.,
ReichartP.,
WolfH.1991; Expression of proteins encoded by Epstein–Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci U S A 88:8332–8336
Ben BassatH.,
GoldblumN.,
MitraniS.7 other authors1977; Establishment in continuous culture of a new type of lymphocyte from a “Burkitt like” malignant lymphoma (line D.G.-75). Int J Cancer 19:27–33
DeckerL. L.,
KlamenL. D.,
Thorley-LawsonD. A.1996; Detection of the latent form of Epstein–Barr virus DNA in the peripheral blood of healthy individuals. J Virol 70:3286–3289
EphrussiA.,
ChurchG. M.,
TonegawaS.,
GilbertW.1985; B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo
. Science 227:134–140
FlemingtonE.,
SpeckS.1990; Identification of phorbol ester response elements in the promoter of Epstein–Barr virus putative lytic switch gene BZLF1. J Virol 64:1217–1226
GutschD.,
Holley GuthrieE.,
ZhangQ.,
KenneyS.1993; NF-kB can physically interact with the Epstein–Barr virus Z protein and inhibit Z function. In XIII International Herpesvirus Workshop, July 25–30. 30
KatzD. A.,
BaumannR. P.,
SunR.,
KolmanJ. L.,
TaylorN.,
MillerG.1992).Viral; proteins associated with the Epstein–Barr virus transactivator, ZEBRA. Proc Natl Acad Sci U S A 89:378–382
KrausR. J.,
MirochaS. J.,
StephanyH. M.,
PuchalskiJ. R.,
MertzJ. E.2001; Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein–Barr virus. J Virol 75:867–877
MiyashitaE. M.,
YangB.,
LamK. M.,
CrawfordD. H.,
Thorley LawsonD. A.1995; A novel form of Epstein–Barr virus latency in normal B cells in vivo
. Cell 80:593–601
MontalvoE. A.,
CottamM.,
HillS.,
WangY.-C. J.1995; YY1 binds to and regulates cis -acting negative elements in the Epstein–Barr virus BZLF1 promoter. J Virol 69:4158–4165
PrangN.,
WolfH.,
SchwarzmannF.1995; Epstein–Barr virus lytic replication is controlled by a posttranscriptional mechanism of BZLF1. J Virol 69:2644–2648
PrangN.,
WolfH.,
SchwarzmannF.1999; Latency of Epstein–Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1. J Med Virol 59:512–519
PschererA.,
DorflingerU.,
KirfelJ.,
GawlasK.,
RuschoffJ.,
BuettnerR.,
SchuleR.1996; The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J 15:6680–6690
RufI. K.,
RawlinsD. R.1995; Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein–Barr virus BZLF1 promoter. J Virol 69:7648–7657
SchwarzmannF.,
PrangN.,
ReicheltB.,
RinkesB.,
HaistS.,
MarschallM.,
WolfH.1994; Negative cis-acting elements in the distal part of the promoter of Epstein–Barr virus trans-activator gene BZLF1. J Gen Virol 75:1999–2006
ShimizuN.,
TakadaK.1994; Analysis of the BZLF1 promoter of Epstein–Barr virus: identification of an anti-immunoglobulin response sequence. J Virol 67:3240–3245
TierneyR. J.,
StevenN.,
YoungL. S.,
RickinsonA. B.1994; Epstein–Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374–7385
WangY. C.,
HuangJ. M.,
MontalvoE. A.1997; Characterization of proteins binding to the ZII element in the Epstein–Barr virus BZLF1 promoter: transactivation by ATF1. Virology 227:323–330
YoungL. S.,
LauR.,
RoweM.7 other authors1991; Differentiation-associated expression of the Epstein–Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65:2868–2874
ZhangQ.,
GutschD.,
KenneyS.1994; Functional and physical interaction between p53 and BZLF1: implications for Epstein–Barr virus latency. Mol Cell Biol 14:1929–1938